Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub-clinical inflammation and the impact on clinical assessment of disease activity

Autor:	Anthony K. Campbell, J. W. Berrill, John Green, Kerenza Hood
Rok vydání:	2013
Předmět:	Adult Male medicine.medical_specialty Inflammation Anxiety Gastroenterology Inflammatory bowel disease Severity of Illness Index Disease activity Irritable Bowel Syndrome Internal medicine Surveys and Questionnaires medicine Humans Pharmacology (medical) In patient Irritable bowel syndrome Depression (differential diagnoses) Hepatology business.industry Depression Middle Aged medicine.disease Inflammatory Bowel Diseases Faecal calprotectin Cross-Sectional Studies Physical therapy Disease Progression Female medicine.symptom business
Zdroj:	Alimentary pharmacologytherapeutics. 38(1)
ISSN:	1365-2036
Popis:	Background: Symptoms compatible with irritable bowel syndrome (IBS) are frequently present in patients with inflammatory bowel disease (IBD); however, the cause of this phenomenon is unclear. Aim: To determine the different contributions of ‘true IBS’ and sub-clinical inflammation in producing IBS-type symptoms in IBD patients, and to ascertain the impact these symptoms have on the clinical assessment of IBD activity. Methods: In this cross-sectional study, 169 IBD patients completed questionnaires to assess disease activity, presence of IBS-type symptoms, and levels of anxiety and depression. Stool samples were collected for analysis of faecal calprotectin (FC). Results: IBS-type symptoms were significantly more common in female patients (OR = 4.64, 1.55–13.88) and were associated with higher levels of anxiety (OR = 1.11, 1.01–1.21). There was no statistical difference between the FC levels of patients in clinical remission with IBS-type symptoms compared with those without (median values = 111 μg/g vs. 45.5 μg/g respectively, P = 0.171). The prevalence of IBS-type symptoms in patients with a normal FC level was 31%. Conclusions A substantial number of IBD patients with normal faecal calprotectin level experience IBS-type symptoms. These patients exhibit similar features to people diagnosed with IBS in the general community, suggesting that the conditions are not mutually exclusive and may coexist in a considerable number of IBD patients. A systematic diagnostic approach is required to assess IBD patients with IBS-type symptoms as sub-clinical inflammation may play a role in a proportion of cases.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dacd9ea11d1d2602f9d8ec7d0d3d294d https://pubmed.ncbi.nlm.nih.gov/23937469 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.